• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

线粒体抗病毒信号蛋白对于肺纤维化的发展至关重要。

Mitochondrial antiviral signaling protein is crucial for the development of pulmonary fibrosis.

机构信息

Section of Pulmonary, Critical Care and Sleep Medicine, Dept of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.

Dept of Pulmonary and Critical Care Medicine, and Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

出版信息

Eur Respir J. 2021 Apr 15;57(4). doi: 10.1183/13993003.00652-2020. Print 2021 Apr.

DOI:10.1183/13993003.00652-2020
PMID:33093124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8559259/
Abstract

Danger signals, or damage-associated molecular patterns (DAMPs), instigate mitochondrial innate immune responses wherein mitochondrial antiviral signaling protein (MAVS) functions as a key platform molecule to mediate them. The role of MAVS in the pathogenesis of idiopathic pulmonary fibrosis (IPF), however, has not yet been identified. Whether MAVS signalling can be modulated by currently existing drugs has also not been explored.We used an established model of pulmonary fibrosis to demonstrate that MAVS is a critical mediator of multiple DAMP signalling pathways and the consequent lung fibrosis after bleomycin-induced injury After bleomycin injury, MAVS expression was mainly observed in macrophages. Multimeric MAVS aggregation, a key event of MAVS signalling activation, was significantly increased and persisted in bleomycin-injured lungs. A proapoptotic BH3 mimetic, ABT-263, attenuated the expression of MAVS and its signalling and, consequently, the development of experimental pulmonary fibrosis. In contrast, the therapeutic effects of nintedanib and pirfenidone, two drugs approved for IPF treatment, were not related to the modulation of MAVS or its signalling. Multimeric MAVS aggregation was significantly increased in lungs from IPF patients as well.MAVS may play an important role in the development of pulmonary fibrosis, and targeting MAVS with BH3 mimetics may provide a novel and much needed therapeutic strategy for IPF.

摘要

危险信号或损伤相关分子模式(DAMPs)引发线粒体固有免疫反应,其中线粒体抗病毒信号蛋白(MAVS)作为关键平台分子介导这些反应。然而,MAVS 在特发性肺纤维化(IPF)发病机制中的作用尚未确定。目前已有的药物是否可以调节 MAVS 信号也尚未得到探索。我们使用已建立的肺纤维化模型证明,MAVS 是多种 DAMPs 信号通路的关键介质,也是博来霉素诱导损伤后肺纤维化的关键介质。在博来霉素损伤后,MAVS 表达主要在巨噬细胞中观察到。多聚 MAVS 聚集,是 MAVS 信号激活的关键事件,在博来霉素损伤的肺中显著增加并持续存在。一种促凋亡 BH3 模拟物 ABT-263 可减弱 MAVS 的表达及其信号转导,从而减轻实验性肺纤维化的发生。相比之下,两种批准用于 IPF 治疗的药物尼达尼布和吡非尼酮的治疗效果与 MAVS 或其信号的调节无关。IPF 患者的肺中也明显增加了多聚 MAVS 聚集。MAVS 可能在肺纤维化的发展中起重要作用,用 BH3 模拟物靶向 MAVS 可能为 IPF 提供一种新的、非常需要的治疗策略。

相似文献

1
Mitochondrial antiviral signaling protein is crucial for the development of pulmonary fibrosis.线粒体抗病毒信号蛋白对于肺纤维化的发展至关重要。
Eur Respir J. 2021 Apr 15;57(4). doi: 10.1183/13993003.00652-2020. Print 2021 Apr.
2
PINK1 Inhibits Multimeric Aggregation and Signaling of MAVS and MAVS-Dependent Lung Pathology.PINK1抑制MAVS的多聚体聚集和信号传导以及MAVS依赖性肺部病理。
Am J Respir Cell Mol Biol. 2021 May;64(5):592-603. doi: 10.1165/rcmb.2020-0490OC.
3
Endocannabinoid signalling/cannabinoid receptor 2 is involved in icariin-mediated protective effects against bleomycin-induced pulmonary fibrosis.内源性大麻素信号传导/大麻素受体 2 参与淫羊藿苷介导的对抗博来霉素诱导的肺纤维化的保护作用。
Phytomedicine. 2022 Aug;103:154187. doi: 10.1016/j.phymed.2022.154187. Epub 2022 May 21.
4
Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects.抑制肥大细胞:尼达尼布发挥抗纤维化作用的新机制。
Thorax. 2020 Sep;75(9):754-763. doi: 10.1136/thoraxjnl-2019-214000. Epub 2020 Jul 24.
5
Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis.靶向 TAM 受体可改善特发性肺纤维化中的纤维化机制。
Am J Respir Crit Care Med. 2018 Jun 1;197(11):1443-1456. doi: 10.1164/rccm.201707-1519OC.
6
Bleomycin Induces Drug Efflux in Lungs. A Pitfall for Pharmacological Studies of Pulmonary Fibrosis.博来霉素诱导肺部药物外排。肺纤维化药物研究的一个陷阱。
Am J Respir Cell Mol Biol. 2020 Feb;62(2):178-190. doi: 10.1165/rcmb.2018-0147OC.
7
Histopathological and molecular analysis of idiopathic pulmonary fibrosis lungs from patients treated with pirfenidone or nintedanib.特发性肺纤维化患者经吡非尼酮或尼达尼布治疗后的肺组织的组织病理学和分子分析。
Histopathology. 2019 Jan;74(2):341-349. doi: 10.1111/his.13745. Epub 2018 Nov 11.
8
The efficacy of pirfenidone in a sheep model of pulmonary fibrosis.吡非尼酮在绵羊肺纤维化模型中的疗效。
Exp Lung Res. 2019 Nov-Dec;45(9-10):310-322. doi: 10.1080/01902148.2019.1695019. Epub 2019 Nov 25.
9
The anti-fibrotic effect of inhibition of TGFβ-ALK5 signalling in experimental pulmonary fibrosis in mice is attenuated in the presence of concurrent γ-herpesvirus infection.在小鼠实验性肺纤维化中,抑制TGFβ-ALK5信号传导的抗纤维化作用在同时存在γ-疱疹病毒感染的情况下会减弱。
Dis Model Mech. 2015 Sep;8(9):1129-39. doi: 10.1242/dmm.019984. Epub 2015 Jul 2.
10
Absence of early metabolic response assessed by 18F-FDG PET/CT after initiation of antifibrotic drugs in IPF patients.特发性肺纤维化患者起始抗纤维化治疗后,18F-FDG PET/CT 评估早期代谢无应答。
Respir Res. 2019 Jan 15;20(1):10. doi: 10.1186/s12931-019-0974-5.

引用本文的文献

1
Tension-induced organelle stress: an emerging target in fibrosis.张力诱导的细胞器应激:纤维化中一个新出现的靶点。
Trends Pharmacol Sci. 2025 Feb;46(2):117-131. doi: 10.1016/j.tips.2024.12.006. Epub 2025 Jan 15.
2
Persistent microbial infections and idiopathic pulmonary fibrosis - an insight into pathogenesis.持续性微生物感染与特发性肺纤维化——发病机制的深入探讨
Front Cell Infect Microbiol. 2024 Dec 20;14:1479801. doi: 10.3389/fcimb.2024.1479801. eCollection 2024.
3
Establishment and validation of a prognostic model for idiopathic pulmonary fibrosis based on mitochondrial-related genes.基于线粒体相关基因的特发性肺纤维化预后模型的建立与验证
J Thorac Dis. 2024 Nov 30;16(11):7427-7445. doi: 10.21037/jtd-24-760. Epub 2024 Nov 14.
4
Advances in non-type 2 severe asthma: from molecular insights to novel treatment strategies.非 2 型严重哮喘的研究进展:从分子认识到新的治疗策略。
Eur Respir J. 2024 Aug 15;64(2). doi: 10.1183/13993003.00826-2023. Print 2024 Aug.
5
Getting the Timing Right: Controlling BCL-2 Inhibition as an Antifibrotic Therapy.把握正确时机:将BCL-2抑制作为抗纤维化疗法进行调控。
Am J Respir Cell Mol Biol. 2024 Apr;70(4):231-232. doi: 10.1165/rcmb.2023-0436ED.
6
Inflammasome activation and metabolic remodelling in p16-positive aging cells aggravates high-fat diet-induced lung fibrosis by inhibiting NEDD4L-mediated K48-polyubiquitin-dependent degradation of SGK1.p16 阳性衰老细胞中炎性小体的激活和代谢重塑通过抑制 NEDD4L 介导的 SGK1 的 K48-多聚泛素依赖性降解加重高脂肪饮食诱导的肺纤维化。
Clin Transl Med. 2023 Jun;13(6):e1308. doi: 10.1002/ctm2.1308.
7
Inhibition of antiapoptotic BCL-2 proteins with ABT-263 induces fibroblast apoptosis, reversing persistent pulmonary fibrosis.ABT-263 通过抑制抗凋亡 BCL-2 蛋白诱导成纤维细胞凋亡,从而逆转持续性肺纤维化。
JCI Insight. 2023 Feb 8;8(3):e163762. doi: 10.1172/jci.insight.163762.
8
VISTA (PD-1H) Is a Crucial Immune Regulator to Limit Pulmonary Fibrosis.VISTA(PD-1H)是限制肺纤维化的关键免疫调节剂。
Am J Respir Cell Mol Biol. 2023 Jul;69(1):22-33. doi: 10.1165/rcmb.2022-0219OC.
9
Mitochondria in Focus: From Function to Therapeutic Strategies in Chronic Lung Diseases.聚焦线粒体:从功能到慢性肺部疾病的治疗策略。
Front Immunol. 2021 Nov 23;12:782074. doi: 10.3389/fimmu.2021.782074. eCollection 2021.
10
Evolving Perspectives on Innate Immune Mechanisms of IPF.特发性肺纤维化固有免疫机制的演变观点
Front Mol Biosci. 2021 Aug 9;8:676569. doi: 10.3389/fmolb.2021.676569. eCollection 2021.

本文引用的文献

1
Recent Advances in Molecular Basis of Lung Aging and Its Associated Diseases.肺衰老及其相关疾病分子基础的最新进展
Tuberc Respir Dis (Seoul). 2020 Apr;83(2):107-115. doi: 10.4046/trd.2020.0003. Epub 2020 Mar 10.
2
STING Polymer Structure Reveals Mechanisms for Activation, Hyperactivation, and Inhibition.STING 聚合物结构揭示了激活、超激活和抑制的机制。
Cell. 2019 Jul 11;178(2):290-301.e10. doi: 10.1016/j.cell.2019.05.036. Epub 2019 Jun 20.
3
Senolytic therapies for healthy longevity.用于健康长寿的衰老细胞清除疗法。
Science. 2019 May 17;364(6441):636-637. doi: 10.1126/science.aaw1299.
4
O-GlcNAc Transferase Links Glucose Metabolism to MAVS-Mediated Antiviral Innate Immunity.O-GlcNAc 转移酶将葡萄糖代谢与 MAVS 介导的抗病毒先天免疫联系起来。
Cell Host Microbe. 2018 Dec 12;24(6):791-803.e6. doi: 10.1016/j.chom.2018.11.001.
5
Immune regulation by fibroblasts in tissue injury depends on uPARAP-mediated uptake of collectins.组织损伤中成纤维细胞的免疫调节依赖于 uPARAP 介导的凝集素摄取。
J Cell Biol. 2019 Jan 7;218(1):333-349. doi: 10.1083/jcb.201802148. Epub 2018 Oct 26.
6
The mitochondria in lung fibrosis: friend or foe?肺纤维化中的线粒体:是敌是友?
Transl Res. 2018 Dec;202:1-23. doi: 10.1016/j.trsl.2018.05.005. Epub 2018 Jun 23.
7
Connective tissue growth factor (CTGF) from basics to clinics.结缔组织生长因子(CTGF):基础与临床。
Matrix Biol. 2018 Aug;68-69:44-66. doi: 10.1016/j.matbio.2018.03.007. Epub 2018 Mar 21.
8
Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis.ABT-263 通过模拟 BH3 靶向肌成纤维细胞凋亡,逆转已建立的纤维化。
Sci Transl Med. 2017 Dec 13;9(420). doi: 10.1126/scitranslmed.aal3765.
9
Mitochondrial dysfunction and damage associated molecular patterns (DAMPs) in chronic inflammatory diseases.慢性炎症性疾病中的线粒体功能障碍和损伤相关分子模式 (DAMPs)。
Mitochondrion. 2018 Jul;41:37-44. doi: 10.1016/j.mito.2017.12.001. Epub 2017 Dec 6.
10
Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function.甲状腺激素通过改善上皮细胞线粒体功能抑制小鼠肺纤维化。
Nat Med. 2018 Jan;24(1):39-49. doi: 10.1038/nm.4447. Epub 2017 Dec 4.